Gottlieb Touts New FDA Science Office, Push for Generic Approvals in 2019

Drug Industry Daily
A A
As the partial government shutdown kept the FDA’s routine activities on hold, FDA Commissioner Scott Gottlieb on Tuesday announced the creation of a new office to help streamline the agency’s review of new drugs.

To View This Article:

Login

Subscribe To Drug Industry Daily